A brighter future for infertility treatment: study

December 5, 2011 in Genetics

A brighter future for infertility treatment: study

The various stages of sperm cell development.

(Medical Xpress) -- Male infertility could soon have a boost through new treatments at a sub-DNA 'epigenetic' level, according to researchers from The Australian National University.

The research team, led by Professor David Tremethick of The John Curtin School of Medical Research at ANU, have uncovered a new mechanism of gene activation which will have important implications in understanding how cellular differentiation is achieved. In the future, it may also allow the development of new approaches to treat . Their research is published in the latest issue of .

The team which included post-doctoral researchers Tanya Soboleva and Maxim Nekrasov made the breakthrough by looking at what’s happening in our bodies at the epigenetic level, which controls how our DNA is expressed.

“Epigenetic information goes beyond DNA-stored information essential for interpreting our genome,” said Professor Tremethick. “There are over 250 different cell types in the human body, and while the DNA sequence of these is essentially the same, their epigenetic information or profiles are very different. Additionally, our entire is compacted into a structure known as chromatin.

“Epigenetic information controls gene expression, ensuring that only genes for a specific cell type are turned on, while inappropriate genes are switched off by ‘opening’ or ‘closing’ the structure of chromatin.

“Regulation of this epigenetic information significantly contributes to embryonic development, and ensures our capacity to reproduce. Mis-regulation of our epigenetic code has been directly implicated in many common human diseases, as well as contributing to human infertility,” he said.

The research team’s study characterized the epigenetic changes that occur during sperm development, and in doing so identified a novel epigenetic mark, called H2A.Lap1.

“Our research revealed that H2A.Lap1 regulates sperm gene expression by directly opening the chromatin structure at the start site of active genes,” said Professor Tremethick.

“The study has therefore uncovered a new way to activate , which could help us understand how is achieved. In the future, this could also allow for the development of treatments for male which operate at the epigenetic level.”

Provided by Australian National University

5 /5 (2 votes)  

Rank 5 /5 (2 votes)
Relevant PhysicsForums posts

More news stories

Researchers develop model for better testing, targeting of malignant peripheral nerve sheath tumors

University of Minnesota Medical School researchers from the Masonic Cancer Center, University of Minnesota, in partnership with the University's Brain Tumor Program, have developed a new mouse model of malignant peripheral ...

Genetics created May 20, 2013 | popularity 5 / 5 (1) | comments 0 | with audio podcast

Researchers identify new circadian clock component

Northwestern University scientists have shown a gene involved in neurodegenerative disease also plays a critical role in the proper function of the circadian clock.

Genetics created May 16, 2013 | popularity 3 / 5 (1) | comments 1 | with audio podcast

Returning genetic incidental findings without patient consent violates basic rights, experts say

Informed consent is the backbone of patient care. Genetic testing has long required patient consent and patients have had a "right not to know" the results. However, as 21st century medicine now begins to use the tools of ...

Genetics created May 16, 2013 | popularity 5 / 5 (1) | comments 3 | with audio podcast

Ethicists provide framework supporting new recommendations on reporting incidental findings in gene sequencing

In a paper published in Science Express, a group of experts led by bioethicists in the Center for Medical Ethics and Health Policy at Baylor College of Medicine provide a framework for the new American College of Medical Geneti ...

Genetics created May 16, 2013 | popularity not rated yet | comments 0

Experts urge caution over use of new genetic sequencing techniques

The use of genome-wide analysis (GWA), where the entirety of an individual's DNA is examined to look for the genomic mutations or variants which can cause health problems is a massively useful technology for diagnosing disease. ...

Genetics created May 16, 2013 | popularity not rated yet | comments 0


If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...

Insight into the dazzling impact of insulin in cells

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.

Antidepressant reduces stress-induced heart condition

A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.